{"ticker": {"uuid": "02ec00ca-860e-489e-96cf-83989b24b16c", "symbol": "NXTMH", "name": "Nexstim Plc", "exchange": "HEL", "country": "FI", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Nexstim : Receives Expanded Health Canada Approval for NBS 6 Diagnostics and Pain Applications", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQOTdPNXoyNVZZSUFoX2VqWF9hTlhXMklhWmYxY3oybF8xbFNnVGZHSWRENnFFQjJCWWZYekFVWkdkV0s0R3Y4NjJYR1NPYW52TTZkdVN1TldyVUtQU0V3ZFRQbkpPZ25aTC1zX1M5XzhmWTdCQzl1cUJqLXM0a3FPOFVxamxIQnRhTWZoa0p6WGFhaW1ocXRHNmdHTkxrbHcyUzZiMjk3QlBqMDNXbVl1RUVyQU1Nd0dSSGc0SmlVUURGNXBpUUhlalFyRWZVSDd0TllpSFZYYUhhVVBoRHc?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T06:08:13+00:00", "published_display": "10 Jul 2026 06:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexstim Plc Secures First NBS 6 Sale in Malaysia Following Malaysian Market Authorization", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPeEZFc2tUYnlaQWswbmczRkNOczFhYkxjQmtTdUloUk5wRndQU2xveTA5VVIydTVGY0xpckdHNFBESHZiZ2x5NE1wMFd5Zm56ZUIyT2swT0d4OElnSndacGxyWEtpaUd2LWkxdlQ3WXdzeTk3WEVuWTEzUGRzNllBekpBbUxSNl9Xc3I1MzY5b1FXelNyczlMV3E5bEJYQk5KRmZuaHhZRXJSR3JvRkpLTmdHbVpBQ0hZRUY5dEs0VHBHWGVKdVlWUEJkUFNzZnRSdWE3cU1BR0VNZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexstim : Secures First NBS 6 Sale Following Malaysian Market Authorization", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPdHJ3VXRDTVBrTjhtem90MHZBVWdhamM4b2NVT2c0dDc2UUl2aWJXblhaWTFtMVdLMWdQMC1WTy1sdXh5MTg2YllzM0ZteUVEcVR4eHJDMmlSdmYtdVRhLUFzVm40d1ZGUDV0ZHpMbFB6QWFWZjVqSWtpUTg0ejVPQi1NOE9YOEN1VExvNnI5Rnc4ODZYN0t4ekJWMGY2V0I0U3UyZF94ejIxYXJyRUxZMkc2T19TM0Y4RzBNdHNHY0R4d05B?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T06:06:13+00:00", "published_display": "08 Jul 2026 06:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexstim: from Helsinki to a global brain revolution", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSjJQTDdPSzBxSlpCR3BRRHdRYzV4Z3ZDT0V3UGRwY0RKWHIzMElrZ3IwMURXTTk1OEFUbkdZd09RQVlSazVKYkhhMHh0Q2Q5UDVZaTE0YjhpdXd3ei1aMlRkeUpJblF3NmVuZERNWi1JcWlTNmpzWnAwVkxmRS1TeGZXd0E2VktwakRDTWtFWEM?oc=5", "source_name": "Biostock", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Nexstim : Receives Expanded Health Canada Approval for NBS 6 Diagnostics and Pain Applications", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQOTdPNXoyNVZZSUFoX2VqWF9hTlhXMklhWmYxY3oybF8xbFNnVGZHSWRENnFFQjJCWWZYekFVWkdkV0s0R3Y4NjJYR1NPYW52TTZkdVN1TldyVUtQU0V3ZFRQbkpPZ25aTC1zX1M5XzhmWTdCQzl1cUJqLXM0a3FPOFVxamxIQnRhTWZoa0p6WGFhaW1ocXRHNmdHTkxrbHcyUzZiMjk3QlBqMDNXbVl1RUVyQU1Nd0dSSGc0SmlVUURGNXBpUUhlalFyRWZVSDd0TllpSFZYYUhhVVBoRHc?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T06:08:13+00:00", "published_display": "10 Jul 2026 06:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexstim Plc Secures First NBS 6 Sale in Malaysia Following Malaysian Market Authorization", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPeEZFc2tUYnlaQWswbmczRkNOczFhYkxjQmtTdUloUk5wRndQU2xveTA5VVIydTVGY0xpckdHNFBESHZiZ2x5NE1wMFd5Zm56ZUIyT2swT0d4OElnSndacGxyWEtpaUd2LWkxdlQ3WXdzeTk3WEVuWTEzUGRzNllBekpBbUxSNl9Xc3I1MzY5b1FXelNyczlMV3E5bEJYQk5KRmZuaHhZRXJSR3JvRkpLTmdHbVpBQ0hZRUY5dEs0VHBHWGVKdVlWUEJkUFNzZnRSdWE3cU1BR0VNZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexstim : Secures First NBS 6 Sale Following Malaysian Market Authorization", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPdHJ3VXRDTVBrTjhtem90MHZBVWdhamM4b2NVT2c0dDc2UUl2aWJXblhaWTFtMVdLMWdQMC1WTy1sdXh5MTg2YllzM0ZteUVEcVR4eHJDMmlSdmYtdVRhLUFzVm40d1ZGUDV0ZHpMbFB6QWFWZjVqSWtpUTg0ejVPQi1NOE9YOEN1VExvNnI5Rnc4ODZYN0t4ekJWMGY2V0I0U3UyZF94ejIxYXJyRUxZMkc2T19TM0Y4RzBNdHNHY0R4d05B?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T06:06:13+00:00", "published_display": "08 Jul 2026 06:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexstim: from Helsinki to a global brain revolution", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSjJQTDdPSzBxSlpCR3BRRHdRYzV4Z3ZDT0V3UGRwY0RKWHIzMElrZ3IwMURXTTk1OEFUbkdZd09RQVlSazVKYkhhMHh0Q2Q5UDVZaTE0YjhpdXd3ei1aMlRkeUpJblF3NmVuZERNWi1JcWlTNmpzWnAwVkxmRS1TeGZXd0E2VktwakRDTWtFWEM?oc=5", "source_name": "Biostock", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 55, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 10.08, "latest_week": "2026-07-17", "one_week_move": 2.6, "four_week_move": 1.4, "twelve_week_move": 10.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.888794, "market_dynamics_buy_signal": false, "relative_strength": -23.614796, "fair_value_gap": 38.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 38.9195, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.6% over one week, +1.4% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 3}, {"label": "Biostock", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.6% over one week, +1.4% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Nexstim : Receives Expanded Health Canada Approval for NBS 6 Diagnostics and Pain Applications"}], "updated_at": "2026-07-18T15:15:49.511806+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}